Clinical Trial Update: Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

View source ↗

Summary

Real-world study results update on tolerability of enzalutamide and abiraterone acetate (with prednisone) in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide) (enzalutamide)
• Zytiga (abiraterone acetate) (abiraterone acetate)

Snippet

Sponsor: Janssen Scientific Affairs, LLC | Conditions: Prostate Cancer | Status: COMPLETED